RSCI (Redwood Scientific Technologies) Land And Improvements : $0.00 Mil (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Redwood Scientific Technologies Land And Improvements?

Redwood Scientific Technologies's land and improvements for the quarter that ended in Dec. 2023 was $0.00 Mil.

Redwood Scientific Technologies Land And Improvements Historical Data

The historical data trend for Redwood Scientific Technologies's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redwood Scientific Technologies Land And Improvements Chart

Redwood Scientific Technologies Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Land And Improvements

Redwood Scientific Technologies Semi-Annual Data
	Dec20	Dec21	Dec22	Dec23
Land And Improvements	-	-	-	-

Redwood Scientific Technologies Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Redwood Scientific Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Redwood Scientific Technologies Inc (OTCPK:RSCI) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

418 Broadway, STE 4872, Albany, NY, USA, 12207

Website

https://www.redwoodsci.co

Redwood Scientific Technologies Inc is a pharmaceutical delivery company that develops, operates, and markets over-the-counter products in a sublingual oral thin film strip. RSCI has begun clinical trials on two new products to market for stopping the addiction to nicotine.